Gapping down
In reaction to disappointing earnings/guidance: CYRN -7.9%, MOBI -6.1%, TTM -4.8%, TOUR -3.6%, WUBA -2.7%, MAGS -0.6%, PLAY -0.4%
Select EU financial related names showing weakness: SAN -2.8%, DB -2%, NBG -1.5%, CS -1.5%, BCS -1.3%
Select metals/mining stocks trading lower with underlying commodity down ~1%: GFI -4.6%, HMY -4.5%, AU -3%, HL -2.2%, GOLD -2.1%, SLV -2%, GG -1.8%, AEM -1.8%, GDX -1.8%, KGC -1.7%, EGO -1.4%, SLW -1.4%, AG -1.1%
Select oil/gas related names showing early weakness with underlying commodity down ~1%: SDRL -3.2%, PBR -2.7%, RIG -2%, RDS.A -1.7%, STO -1.7%, TOT -1.4%
Other news: IMRS -17.7% (IMRIS and two subsidiaries confirm filing for Chapter 11 bankruptcy protection), ACI -9.4% (receives continued listing standard notice from NYSE; taking steps to regain compliance with minimum share price standard), INO -3.7% (files for $250 mln mixed securities shelf offering), POZN -3.1% (confirms that on May 21, 2015, The Coalition for Affordable Drugs VII LLC filed a Petition for Inter Partes Review of POZEN Inc.'s U.S. Patent No. 6,926,907), SHAK -2.7% (modest pullback following strong gains last week), PBR -2.7% (still checking), AZN -1.7% (confirmed the termination of its co-development and commercialisation agreement with Amgen (AMGN) for brodalumab), AMGN -1.1% (commenced termination of its participation in the co-development and commercialization of brodalumab with AstraZeneca (AZN))
Analyst comments: ANR -5.2% (initiated with a Underperform at Credit Suisse), FSLR -3.8% (downgraded to Underperform from Sector Perform at RBC Capital Mkts), NBR -2% (downgraded to Underperform from Outperform at Credit Agricole), HW -1.3% (downgraded to Neutral from Outperform at Wedbush), DE -0.7% (downgrade to Neutral at Robert W. Baird ), HBAN -0.7% (downgraded to Underperform from Neutral at Macquarie
)
In reaction to disappointing earnings/guidance: CYRN -7.9%, MOBI -6.1%, TTM -4.8%, TOUR -3.6%, WUBA -2.7%, MAGS -0.6%, PLAY -0.4%
Select EU financial related names showing weakness: SAN -2.8%, DB -2%, NBG -1.5%, CS -1.5%, BCS -1.3%
Select metals/mining stocks trading lower with underlying commodity down ~1%: GFI -4.6%, HMY -4.5%, AU -3%, HL -2.2%, GOLD -2.1%, SLV -2%, GG -1.8%, AEM -1.8%, GDX -1.8%, KGC -1.7%, EGO -1.4%, SLW -1.4%, AG -1.1%
Select oil/gas related names showing early weakness with underlying commodity down ~1%: SDRL -3.2%, PBR -2.7%, RIG -2%, RDS.A -1.7%, STO -1.7%, TOT -1.4%
Other news: IMRS -17.7% (IMRIS and two subsidiaries confirm filing for Chapter 11 bankruptcy protection), ACI -9.4% (receives continued listing standard notice from NYSE; taking steps to regain compliance with minimum share price standard), INO -3.7% (files for $250 mln mixed securities shelf offering), POZN -3.1% (confirms that on May 21, 2015, The Coalition for Affordable Drugs VII LLC filed a Petition for Inter Partes Review of POZEN Inc.'s U.S. Patent No. 6,926,907), SHAK -2.7% (modest pullback following strong gains last week), PBR -2.7% (still checking), AZN -1.7% (confirmed the termination of its co-development and commercialisation agreement with Amgen (AMGN) for brodalumab), AMGN -1.1% (commenced termination of its participation in the co-development and commercialization of brodalumab with AstraZeneca (AZN))
Analyst comments: ANR -5.2% (initiated with a Underperform at Credit Suisse), FSLR -3.8% (downgraded to Underperform from Sector Perform at RBC Capital Mkts), NBR -2% (downgraded to Underperform from Outperform at Credit Agricole), HW -1.3% (downgraded to Neutral from Outperform at Wedbush), DE -0.7% (downgrade to Neutral at Robert W. Baird ), HBAN -0.7% (downgraded to Underperform from Neutral at Macquarie
)